Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012222 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Keyla S G de Sá und 18 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão P…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Virus Replication, Viral Load. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Sao Paulo (FAPESP), FAPESP, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (Originalsprache)
COVID-19 has affected more than half a billion people worldwide, with more than 6.3 million deaths, but the pathophysiological mechanisms involved in lethal cases and the host determinants that determine the different clinical outcomes are still unclear. In this study, we assessed lung autopsies of 47 COVID-19 patients and examined the inflammatory profiles, viral loads, and inflammasome activation. Additionally, we correlated these factors with the patient’s clinical and histopathological conditions. Robust inflammasome activation was detected in the lungs of lethal cases of SARS-CoV-2. Experiments conducted on transgenic mice expressing hACE2 and infected with SARS-CoV-2 showed that Nlrp3 -/- mice were protected from disease development and lethality compared to Nlrp3 +/+ littermate mice, supporting the involvement of this inflammasome in disease exacerbation. An analysis of gene expression allowed for the classification of COVID-19 patients into two different clusters. Cluster 1 died with higher viral loads and exhibited a reduced inflammatory profile than Cluster 2. Illness time, mechanical ventilation time, pulmonary fibrosis, respiratory functions, histopathological status, thrombosis, viral loads, and inflammasome activation significantly differed between the two clusters. Our data demonstrated two distinct profiles in lethal cases of COVID-19, thus indicating that the balance of viral replication and inflammasome-mediated pulmonary inflammation led to different clinical outcomes. We provide important information to understand clinical variations in severe COVID-19, a process that is critical for decisions between immune-mediated or antiviral-mediated therapies for the treatment of critical cases of COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.
- Departamento de Patologia e Medicina Legal, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.
- Departamento de Imagens Médicas, Hematologia e Oncologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.
ORCID-Profile: Dario S Zamboni
Förderung
- Fundação de Amparo à Pesquisa do Estado de Sao Paulo (FAPESP)
- FAPESP
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
de Sá, K. S. G., Amaral, L. A., Rodrigues, T. S., Caetano, C. C. S., Becerra, A., Batah, S. S., Lopes, F. T., de Oliveira, I. M., Lopes, L. S., Almeida, L., Mota, C. M., Oliveira, S., Wada, D. T., Koenigkam-Santos, M., Martins, R. B., Rosales, R. R. C., Arruda, E., Fabro, A. T., & Zamboni, D. S. (2024). Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012222
Vancouver
de Sá KSG, Amaral LA, Rodrigues TS, Caetano CCS, Becerra A, Batah SS, et al. Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012222
BibTeX
@article{deS2024,
author = {de Sá, Keyla S G and Amaral, Luana A and Rodrigues, Tamara S and Caetano, Camila C S and Becerra, Amanda and Batah, Sabrina S and Lopes, Felipe T and de Oliveira, Isadora M and Lopes, Letícia S and Almeida, Leticia and Mota, Caroline M and Oliveira, Samuel and Wada, Danilo T and Koenigkam-Santos, Marcel and Martins, Ronaldo B and Rosales, Roberta R C and Arruda, Eurico and Fabro, Alexandre T and Zamboni, Dario S},
title = {Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012222}
}
EUVIMED